Improved Public Awareness and Immunotherapy Drive Down Melanoma Mortality Amid Rising Incidences
SOURCE: OncLive, May 2025
Author(s): Courtney Flaherty
Fact checked by: Ashley Chan
Vincent Ma, MD, discusses progress in the management of advanced-stage melanoma and the need for primary prevention during Skin Cancer Awareness Month.
Although the incidence of melanoma has increased significantly over the past several decades, melanoma-related mortality rates have declined—an encouraging trend that reflects both improved public awareness and the impact of modern immunotherapy regimens, according to Vincent Ma, MD.
“[Immunotherapy] is an ever-evolving field,” Ma said in an interview with OncLive®. “As we consider more combination therapies to reduce recurrence, particularly with individualized neoadjuvant strategies, it will be exciting to see how these approaches fit into the broader neoadjuvant treatment landscape.”